Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
Wang M, Wang W, Abeywardane A, Adikarama M, McLornan D, Raj K, de Lavallade H, Devereux S, Mufti GJ, Pagliuca A, Potter VT, Mijovic A. Wang M, et al. Among authors: mijovic a. Biol Blood Marrow Transplant. 2015 Jan;21(1):60-6. doi: 10.1016/j.bbmt.2014.09.009. Epub 2014 Sep 28. Biol Blood Marrow Transplant. 2015. PMID: 25262883 Free article.
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S, Mufti GJ. Ho AY, et al. Among authors: mijovic a. Blood. 2004 Sep 15;104(6):1616-23. doi: 10.1182/blood-2003-12-4207. Epub 2004 Apr 1. Blood. 2004. PMID: 15059843 Free article. Clinical Trial.
Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.
Parker JE, Shafi T, Pagliuca A, Mijovic A, Devereux S, Potter M, Prentice HG, Garg M, Yin JA, Byrne J, Russell NH, Mufti GJ. Parker JE, et al. Among authors: mijovic a. Br J Haematol. 2002 Oct;119(1):144-54. doi: 10.1046/j.1365-2141.2002.03796.x. Br J Haematol. 2002. PMID: 12358919 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 33067624
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
Marsh JC, Stanworth SJ, Pankhurst LA, Kallon D, Gilbertson AZ, Pigden C, Deary AJ, Mora AS, Brown J, Laing ES, Choo LL, Hodge R, Llewelyn CA, Harding K, Sage D, Mijovic A, Mufti GJ, Navarrete CV, Brown CJ. Marsh JC, et al. Among authors: mijovic a. Blood. 2021 Jan 21;137(3):310-322. doi: 10.1182/blood.2020007199. Blood. 2021. PMID: 33475737 Free article. Clinical Trial.
P15INK4B is not mutated in adult familial myelodysplastic syndromes.
Cameron E, Mijovic A, Herman JG, Baylin SB, Pradhan A, Mufti GJ, Rassool FV. Cameron E, et al. Among authors: mijovic a. Br J Haematol. 2002 Oct;119(1):277-9. doi: 10.1046/j.1365-2141.2002.37707.x. Br J Haematol. 2002. PMID: 12358941 Free article. No abstract available.
80 results